PriceTargets.com logo

Uniphar - UPR Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: GBX 310
  • Forecasted Upside: 22.05%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
GBX 254 As of 05/2/2025 01:20 PM ET
▲ +2 (0.79%)

This chart shows the closing price for UPR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
MarApr254.00Closing price on 05/02/25:
Get New Uniphar Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for UPR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for UPR

Analyst Price Target is GBX 310
▲ +22.05% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Uniphar in the last 3 months. The average price target is GBX 310, with a high forecast of GBX 310 and a low forecast of GBX 310. The average price target represents a 22.05% upside from the last price of GBX 254.

This chart shows the closing price for UPR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart
5/247/2410/241/255/255/26114163212261310Closing price on 05/02/25: 254.00High310.00Average310.00Low310.00




Current Consensus is Buy

The current consensus among 2 contributing investment analysts is to buy stock in Uniphar.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/10/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/8/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/8/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/6/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/4/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/2/2025
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/3/2025
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/3/2025

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/25/2025Shore CapitalReiterated RatingBuy
1/28/2025Shore CapitalReiterated RatingBuy
9/4/2024Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 310
3/22/2023Shore CapitalReiterated RatingBuy
8/2/2021Shore CapitalReiterated RatingBuy
7/20/2021Shore CapitalReiterated RatingBuy
5/12/2021Shore CapitalReiterated RatingBuy
3/2/2021Shore CapitalReiterated RatingBuy
(Data available from 5/3/2020 forward)

News Sentiment Rating

0.32 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
1/3/2025
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
2/2/2025
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/4/2025
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/3/2025
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/3/2025

Current Sentiment

  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Uniphar logo
Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.
Read More

Today's Range

Now: GBX 254
Low: 250
High: 254

50 Day Range

MA: GBX 228.42
Low: 210.25
High: 254

52 Week Range

Now: GBX 254
Low: 163
High: 254

Volume

17,081 shs

Average Volume

29,710 shs

Market Capitalization

£790.66 million

P/E Ratio

17.66

Dividend Yield

0.77%

Beta

0.75

Frequently Asked Questions

What sell-side analysts currently cover shares of Uniphar?

The following Wall Street analysts have issued research reports on Uniphar in the last twelve months: Deutsche Bank Aktiengesellschaft, and Shore Capital.
View the latest analyst ratings for UPR.

What is the current price target for Uniphar?

0 Wall Street analysts have set twelve-month price targets for Uniphar in the last year. Their average twelve-month price target is GBX 310, suggesting a possible upside of 22.0%. Deutsche Bank Aktiengesellschaft has the highest price target set, predicting UPR will reach GBX 310 in the next twelve months. Deutsche Bank Aktiengesellschaft has the lowest price target set, forecasting a price of GBX 310 for Uniphar in the next year.
View the latest price targets for UPR.

What is the current consensus analyst rating for Uniphar?

Uniphar currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe UPR will outperform the market and that investors should add to their positions of Uniphar.
View the latest ratings for UPR.

What other companies compete with Uniphar?

Other companies that are similar to Uniphar include UDG Healthcare, Abcam, HUTCHMED, Indivior and Clinigen Group. Learn More about companies similar to Uniphar.

How do I contact Uniphar's investor relations team?

Uniphar's physical mailing address is 4045 Kingswood Road, Citywest Business Park, Dublin D24 V06K, Ireland. The company's listed phone number is 353 1 428 7777. The official website for Uniphar is www.uniphar.ie. Learn More about contacing Uniphar investor relations.